MPL and myeloproliferative neoplasm: Since detecting these mutations is  valuable in diagnosis and no study has been done to determine the frequency of this mutation in Iranian patients, this study planned to evaluate primarily the prevalence of c-MPL gene mutation in MPD patients (ET and PMF subgroups) and secondly, the relation of these mutations with laboratory and clinical results of patients.